Authors

• Marijke R. van Dijk (ORCID: https://orcid.org/0009-0003-6344-5736)
• Willeke A.M. Blokx (ORCID: https://orcid.org/0000-0002-4647-8830)
• Chiel F Ebbelaar (ORCID: https://orcid.org/0000-0001-6656-8967)
• Lourens T. Bloem (ORCID: https://orcid.org/0000-0002-0014-8625)
• Frans Schutgens (ORCID: https://orcid.org/0009-0007-5642-7440)
• Remco van Doorn (ORCID: https://orcid.org/0000-0002-7019-6673)
• Anne M.R. Schrader (ORCID: https://orcid.org/0000-0003-3483-0558)
• Gerben Eise Breimer (ORCID: https://orcid.org/0000-0003-0365-3667)
• Karijn P.M. Suijkerbuijk (ORCID: https://orcid.org/0000-0003-3604-5430)
• Wendy W.J. de Leng (ORCID: https://orcid.org/0000-0003-2911-6018)
• Anne M.L. Jansen
• Anne‐Marie Cleton‐Jansen
• Leonie C M Speet
• Sietske Zoetemeyer

Institutions

• Leiden University (NL)
• Utrecht University (NL)
• Leiden University Medical Center (NL)
• University Medical Center Utrecht (NL)
• Reinier de Graaf Hospital (NL)
• Oncode Institute (NL)

Publication Details

Journal

EBioMedicine

Published

2025-03-18

DOI

https://doi.org/10.1016/j.ebiom.2025.105643

Citations

3

Primary Topic

Melanoma and MAPK Pathways

Type

article

Field-Weighted Citation Impact

2.42

Funders

• Hanarth Fonds